Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Van Poppel

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Asian Journal of Urology|March 8, 2018
Locally advanced and high risk prostate cancer: The best indication for initial radical prostatectomy?Hendrik van Poppel
Cancer Management and Research|December 29, 2010
Evaluation of degarelix in the management of prostate cancerHendrik Van Poppel
Cancer Management and Research|June 2, 2011
Chemoprevention of prostate cancer with nutrients and supplementsHendrik Van Poppel, Bertrand Tombal
European Urology|August 3, 2007
Is surveillance an option for the treatment of small renal masses?Hendrik Van Poppel, Steven Joniau
Urology|April 15, 2008
Testosterone surge: rationale for gonadotropin-releasing hormone blockers?Hendrik van Poppel, Sten Nilsson
Therapeutic Advances in Urology|February 2, 2012
Emerging novel therapies for advanced prostate cancerSusanne Osanto, Hendrik Van Poppel
European Urology|October 24, 2007
An analysis of radical prostatectomy in advanced stage and high-grade prostate cancerHendrik Van Poppel, Steven Joniau
International Journal of Urology : Official Journal of the Japanese Urological Association|July 15, 2020
Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancerHendrik Van Poppel, Per-Anders Abrahamsson
Urologia Internationalis|September 18, 2014
Salvage Pelvic Lymph Node Dissection after Radical Prostatectomy for Biochemical and Lymph Node RecurrenceCharlotte Peeters, Diederik Ponette, Hendrik van Poppel
Future Oncology (London, England)|August 29, 2013
Tasquinimod: a novel drug in advanced prostate cancerSusanne Osanto, Hendrik van Poppel, Jacobus Burggraaf
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Asian Journal of Urology|March 8, 2018
Locally advanced and high risk prostate cancer: The best indication for initial radical prostatectomy?Hendrik van Poppel
Cancer Management and Research|December 29, 2010
Evaluation of degarelix in the management of prostate cancerHendrik Van Poppel
Cancer Management and Research|June 2, 2011
Chemoprevention of prostate cancer with nutrients and supplementsHendrik Van Poppel, Bertrand Tombal
European Urology|August 3, 2007
Is surveillance an option for the treatment of small renal masses?Hendrik Van Poppel, Steven Joniau
Urology|April 15, 2008
Testosterone surge: rationale for gonadotropin-releasing hormone blockers?Hendrik van Poppel, Sten Nilsson
Therapeutic Advances in Urology|February 2, 2012
Emerging novel therapies for advanced prostate cancerSusanne Osanto, Hendrik Van Poppel
European Urology|October 24, 2007
An analysis of radical prostatectomy in advanced stage and high-grade prostate cancerHendrik Van Poppel, Steven Joniau
International Journal of Urology : Official Journal of the Japanese Urological Association|July 15, 2020
Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancerHendrik Van Poppel, Per-Anders Abrahamsson
Urologia Internationalis|September 18, 2014
Salvage Pelvic Lymph Node Dissection after Radical Prostatectomy for Biochemical and Lymph Node RecurrenceCharlotte Peeters, Diederik Ponette, Hendrik van Poppel
Future Oncology (London, England)|August 29, 2013
Tasquinimod: a novel drug in advanced prostate cancerSusanne Osanto, Hendrik van Poppel, Jacobus Burggraaf
Pageof 22